» Articles » PMID: 8755666

Neutrophil Infiltration, Glial Reaction, and Neurological Disease in Transgenic Mice Expressing the Chemokine N51/KC in Oligodendrocytes

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1996 Jul 15
PMID 8755666
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Chemokines (pro-inflammatory chemoattractant cytokines) are expressed in pathological conditions of the central nervous system (CNS). Previous studies suggested that the CNS is relatively resistant to leukocyte diapedesis after chemokine injection, leaving their functional role unresolved. The CNS function of N51/KC, a neutrophil-selective chemokine, was addressed by expressing N51/KC under control of the myelin basic protein (MBP) promoter in transgenic (tg) mice (MBP-N51/KC mice). CNS-specific N51/KC expression produced remarkable neutrophil infiltration into perivascular, meningeal, and parenchymal sites, demonstrating that this chemokine exerts the multiple functions in vivo required to recruit leukocytes into the CNS. MBP-N5 1/KC mice represent an incisive model for the molecular dissection of neutrophil entry into the CNS. Unexpectedly, MBP-N51/KC mice developed a neurological syndrome of pronounced postural instability and rigidity at high frequency beginning at 40 days of age, well after peak chemokine expression. 68/182 mice in one tg fine were found dead before one year of age, with prominent neurological symptoms premortem in 26 (38%). Florid microglial activation and blood-brain barrier disruption without dysmyelination were the major neuropathological alterations. Late-onset neurological symptoms in MBP-N51/KC mice may indicate unanticipated consequences of CNS chemokine expression.

Citing Articles

Neutrophil biology in injuries and diseases of the central and peripheral nervous systems.

Balog B, Sonti A, Zigmond R Prog Neurobiol. 2023; 228:102488.

PMID: 37355220 PMC: 10528432. DOI: 10.1016/j.pneurobio.2023.102488.


Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma.

Chen Z, Soni N, Pinero G, Giotti B, Eddins D, Lindblad K Nat Commun. 2023; 14(1):1839.

PMID: 37012245 PMC: 10070461. DOI: 10.1038/s41467-023-37361-8.


Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease.

Rossi B, Santos-Lima B, Terrabuio E, Zenaro E, Constantin G Front Immunol. 2021; 12:639369.

PMID: 33679799 PMC: 7933037. DOI: 10.3389/fimmu.2021.639369.


Astrocyte- and Neuron-Derived CXCL1 Drives Neutrophil Transmigration and Blood-Brain Barrier Permeability in Viral Encephalitis.

Michael B, Bricio-Moreno L, Sorensen E, Miyabe Y, Lian J, Solomon T Cell Rep. 2020; 32(11):108150.

PMID: 32937134 PMC: 7548103. DOI: 10.1016/j.celrep.2020.108150.


Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice.

Nakamura A, Uratsuji H, Yamada Y, Hashimoto K, Nozawa N, Matsumoto T Mycoses. 2019; 63(2):189-196.

PMID: 31724251 PMC: 7003819. DOI: 10.1111/myc.13034.


References
1.
Eng L . Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 1985; 8(4-6):203-14. DOI: 10.1016/s0165-5728(85)80063-1. View

2.
Tani M, Glabinski A, Tuohy V, Stoler M, Estes M, Ransohoff R . In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol. 1996; 148(3):889-96. PMC: 1861709. View

3.
Perry V, Andersson P . The inflammatory response in the CNS. Neuropathol Appl Neurobiol. 1992; 18(5):454-9. DOI: 10.1111/j.1365-2990.1992.tb00811.x. View

4.
Cserr H, Knopf P . Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today. 1992; 13(12):507-12. DOI: 10.1016/0167-5699(92)90027-5. View

5.
Araujo D, Cotman C . Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 1993; 600(1):49-55. DOI: 10.1016/0006-8993(93)90400-h. View